New From Blue Header

August 2007

bullet

New Disease Management Phone Number for Fully-Insured Members

bullet

BlueCard Claim Payments

bullet
bullet New Pharmacy Prior Authorization Programs
bullet Sending Kids Off to College?
bullet Compare Cost and Quality


GIVE US YOUR FEEDBACK

E-mail your comments or
ideas for future stories to NewsFromBlue@wellmark.com


BLUE REVIEW

Click here to view the 3rd/4th Quarter 2006 issue.


EMPLOYER TOOLKIT
Not a registered user of the Employer Toolkit? Contact your Wellmark account manager to get signed up.

WELCOME TO NEWS FROM BLUE,SM CREATED TO HELP YOU BETTER MANAGE YOUR HEALTH PLAN BY KEEPING YOU UP-TO-DATE ON THE LATEST INFORMATION FROM WELLMARK BLUE CROSS AND BLUE SHIELD. NEWS FROM BLUE WILL BE E-MAILED TO YOU MONTHLY, AND ARCHIVED ON WWW.WELLMARK.COM.
pharmacy news

New Disease Management Phone Number For Fully-Insured Members

Starting September 1, employees participating in Wellmark Blue Cross and Blue Shield’s Disease Management program have a new phone number to call for help managing their chronic health conditions — 1-866-816-5264.

Fully-insured members currently participating in a Disease Management program will receive a letter in late August explaining the change, followed by a phone call with more information.

Wellmark’s Disease Management services provide help to plan members with diabetes, chronic respiratory diseases, and heart conditions to coordinate their health care, understand and follow their physician’s treatment plans, and maintain healthy behaviors.

contact

Disease Management is a standard feature of all fully-insured plans, and a buy-up option for self-funded employers. Learn more about Wellmark’s health management programs by selecting Products and Services in the Employer section of www.wellmark.com.

Back to top


BlueCard® Claim Payments

Wellmark Blue Cross and Blue Shield changed the way BlueCard claims are paid for members receiving services from non-participating providers located in states other than Iowa and South Dakota. As of July 1, for BlueCard claims associated with non-participating providers, Wellmark now pays the lesser of the:

  • Wellmark Maximum Allowable Fee (MAF), or
  • Amount allowed by the local plan where the Wellmark customer received services

Prior to the program start date, Wellmark paid the lesser of the provider’s billed charge or the Wellmark MAF. International claims, and claims for Med Advantage, Medicaid, and Medicare Supplement continue to be priced at charge. Minimal impact is expected from the change, as only 1 percent of BlueCard claims Wellmark receives are for services from non-participating providers.

contact

Contact your Wellmark agent or direct representative for more information about the payment changes or other BlueCard questions.

Back to top


HEDIS® Name Changes but Acronym Remains the Same

The National Committee for Quality Assurance (NCQA) is changing the naming convention for HEDIS® or “Health Plan Employer Data and Information Set.”  NCQA is retaining the HEDIS acronym, but changing the underlying name to “Health Care Effectiveness Data and Information Set” to reflect an expanded scope of health care performance measures.
contact

HEDIS is one of multiple data sets used to identify opportunities to improve services to members and customer groups.  Learn more about Wellmark’s Quality Management Program by visiting Health Improvement Report on www.wellmark.com.

Back to top
plan news

New Pharmacy Prior Authorization Programs

Wellmark Blue Cross and Blue Shield is implementing three new pharmacy prior authorization programs to encourage generic drug use and
support the most clinically effective drug therapy at the lowest net spend.

Sedative Hypnotics Prior Authorization
Sedative hypnotics are sleep aid drugs such as Ambien, Ambien CR, Sonata, Lunesta, and Rozerem. To encourage use of generic Ambien, Wellmark is implementing a new prior authorization process for sedative hypnotics effective September 15, 2007.

Under the new program, a member must try and fail generic Ambien (zolpidem tartrate) before coverage is available for Ambien CR, Sonata, Lunesta, and Rozerem. This program goes into effect for all members currently taking a sedative hypnotic, as well as new users.

If the physician would like the member to continue on their current sedative hypnotic drug rather than move to generic Ambien and there is no claims history in the system for Ambien or its generic equivalent, the physician will need to request approval from Wellmark. Approval will be granted if the physician can document that the member has tried and failed Ambien in the past.

Generic Ambien is a Tier 1 drug on the Wellmark Drug List, while the other sedative hypnotics are on Tier 3. In May, Wellmark sent a postcard to all members taking a sedative hypnotic to inform them about the availability of generic Ambien and how this new option may help decrease their out-of-pocket costs.

Drug Name Dosage Number of Tablets Price
Generic Ambien
(zolpidem tartrate)
5 mg
10 mg
30
30
$15.39
$19.39
Ambien

5 mg
10 mg

30
30
$134.12
$134.12
Ambien CR 6.25 mg
12.5 mg
30
30
$109.17
$109.17
Sonata 5 mg
10 mg
30
30
$106.91
$103.63
Lunesta 1 mg
2 mg
3 mg
30
30
30
$125.34
$127.52
$127.52
Rozerem 8 mg
30
$95.46
Prices from www.drugstore.com, July 19, 2007

Non-Sedating Antihistamine Prior Authorization
The FDA recently approved a new drug called Xyzal, a non-sedating antihistamine. Xyzal is similar to both Allegra (which is also available as a generic) and Zyrtec (which is expected to be available without a prescription in 2008, similar to Claritin).

To encourage the use of established non-sedating antihistamines, Wellmark has implemented a prior authorization for Xyzal. Members will be required to try and fail generic Allegra and Zyrtec before coverage is available for Xyzal.

Because the prior authorization was in place before Xyzal was available to purchase (although the drug has been approved by the FDA, it was not being sold at the time this newsletter was published), this prior authorization does not impact current users of non-sedating antihistamines.

Antifungal Prior Authorization Change
Antifungals are drugs such as Penlac, Sporanox, and Lamisil that are frequently used to treat nail fungus (onychomychosis), which is generally considered a cosmetic condition. These drugs currently require a prior authorization. Effective September 15, 2007, Wellmark is changing its prior authorization criteria to no longer provide coverage for Penlac, Sporanox, Lamisil, and their generic equivalents when prescribed for cosmetic purposes.

If the antifungal is being prescribed for medical rather than cosmetic purposes, the physician will need to submit a prior authorization request to Wellmark for approval.

Wellmark currently has similar prior authorization policies in place for drugs such as Retin-A. Coverage for Retin-A is not available if it is being prescribed for treatment of wrinkles, which is considered a cosmetic condition. But Retin-A is covered for a diagnosis such as skin cancer, for example, if prior authorization approval is received.

contact

Members currently taking these drugs and physicians who have patients affected by the prior authorization requirements will receive letters in mid-August alerting them about the changes. Providers are also being informed of the new Xyzal prior authorization requirement.

Back to top
manage your plan

Sending Kids Off to College?

Do your employees have dependent children who will attend college full-time out-of-state? Wellmark Health Plan of Iowa has an added benefit for employees and their family members while away from home for 90 or more consecutive days. Guest Memberships include access to Blue Cross and Blue Shield participating hospitals, physicians, and other related health care providers from which members can receive covered services. Important: Preventive services are not covered unless performed by the member’s designated Wellmark Health Plan of Iowa primary care provider.

contact

How to set up a Guest Membership:

  • Notify a Wellmark Health Plan of Iowa customer service representative
  • Select a physician from a participating Blue network that will provide your care. To request a list of health care providers for your out-of-area location, call 1-800-810-BLUE (2583) or go to the national BlueCard Doctor and Hospital Finder at www.bcbs.com.
  • Carry your current Wellmark ID card.
  • Present your ID card to your health care provider when receiving services.
Back to top
Better Health Header

Compare Cost and Quality

Help making health care choices
Information is critical in helping your employees manage their health care and make informed decisions. Members have access to a growing range of data on health care cost and quality on www.wellmark.com to help them decide where to seek medical care. Visit Health Care Quality & Cost on the Member or Employer Sections to find these health care resources:

Treatment Cost Estimator Select Quality Care My Health Care
Cost Tools
See cost estimates by ZIP code for more than 600 medical conditions. Compare hospitals for more than 150 procedures and diagnoses.

As a registered member access:

  • Check My Claims
  • View Eligibility & Benefits
  • Wellmark Drug List

More Employer Tools
Wellmark also participates in the Blue Distinction Hospital Measurement and Improvement ProgramSM, which gives group decision-makers access to quality data for hospitals that contract with The Blues®. Access to this tool is currently limited to plan administrators registered to use www.wellmark.com.

contact

For more help in educating employees about health care costs, check out the new Decisions Count® “Health Care Consumerism 101: Putting Yourself in the Driver’s Seat” education module on the Employer Toolkit.

Back to top
Copyright© 2007 Wellmark, Inc. All Rights Reserved.
Wellmark Blue Cross and Blue Shield is an Independent Licensee of the Blue Cross and Blue Shield Association.
Blue Cross®, Blue Shield®, and the Cross® and Shield® symbols are registered marks of the Blue Cross and
Blue Shield Association, an Association of Independent Blue Cross and Blue Shield Plans.